Artificial intelligence

FDA plans to fully tap real-world data and evidence

reprint The Food and Drug Administration plans to exploit claims, clinical and patient-generated data— information not captured through traditional clinical trials—for post-marketing safety surveillance. “New streams of real-world data gathered from electronic health records, lab tests, wearable devices, insurance claims and even social media can provide important evidence on product Czytaj więcej…

Disease management programs

Tech powers Brigham and Women’s Hospital home-based hypertension program

reprint A new home-based care delivery program is able to rapidly improve hypertension control rates while significantly lowering cost, compared with traditional office-based blood pressure interventions. Developed by Boston’s Brigham and Women’s Hospital, the program leverages an expert‐developed clinical algorithm, Bluetooth‐enabled devices that provide home blood pressure measurements transmitted wirelessly Czytaj więcej…